Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Crohn)
Medicinal Chemistry
CNS
Synaptopathies
in vitro Pharmacology
Drug Discovery and Development
Health Care
Oncology
IBD (Colitis
IP generation
Date founded
2016
Funding rounds raised
M
MEDIBIOFARMA SL raised undisclosed on March 20, 2023
Investors: Crohn's & Colitis Foundation of America